Biological Dating of Cerebral Ischemia With GST-π/PRDX1 to Detect Patients With Stroke of Unknown Onset Within the Therapeutic Window of Thrombolysis "FLAG1"

Not yet recruiting

Phase N/A Results N/A

Summary of Purpose

The FLAG1 study will assess the diagnostic performance of biomarkers Glutathion S-Transferase-π (GST-π) and Peroxyredoxin 1 (PRDX1) to identify cerebral infarction of less than 4,5 hours in a population of patients with neurological deficiency of less than 12 hours.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 November 2017.

1 Jan 2018 23 Nov 2017 1 Jan 2021 1 Jul 2021 1 Nov 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts